Dynamics of accessibility of medicines for type 2 diabetes monotherapy in Ukraine

Journal Title: Фармацевтичний журнал - Year 2017, Vol 1, Issue 1

Abstract

Diabetes mellitus is recognized as noninfectious epidemic in the world. Antidiabetic medications for the patients are taking continually and they are expensive. So, the actual question is the evaluation of the economic availability of antidiabetic treatment. Compared with other similar researches the economic availability of monotherapy of type 2 diabetes mellitus in Ukraine has not been investigated. It was researched in this study. The purpose of the research was scientific generalization of the results of study of the economic availability of monotherapy of type 2 diabetes mellitus in Ukraine from 2013 to 2016. The material of the study were: ATC/DDD-indexes of Centre WHO methodology of statistical studies of drugs, cost of DDDs was calculated according to weighed average cost in November 2013 and November 2016, according to weekly «Pharmacy» information. Methods: frequency analysis, ATC/DDD-methodology, the calculation of socio-economic coefficients of accessibility: liquidity ratio (Cliq), solvency adequacy ratio (Ca.s.), availability ratio (D). Based on the results of our previous studies to analyze the dynamics of socio-economic accessibility have been selected schemes of monotherapy with metformin, gliclazide and glimepiride, as the most commonly used in clinical practice. It has been found that the minimum price for DDD of metformin increased by 101%, for glimepiride – by 65%, for gliclazide – by 41% from 2013 to 2016. In the study of liquidity ratio Cliq, it has been found that there was an increase of price fluctuations from 48 to 295%. In the study of the solvency adequacy ratio Ca.s., it has been found that the accessibility has decreased from 98 to 197%, respectively. In studying of availability ratio D it has been found that the growth rate of salary was lower rates therapy price increases by 67% for metformin, by 44% for glimepiride, by 5% for gliclazide. In the study of economic availability it has been found an increase in prices in 1.4 times for metformin, in 1.25 times – for glimepiride, in 4.3 times – for gliclazide. Accessibility of monotherapy of type 2 diabetes mellitus has been decreased by 98–197%. The rate of wage growth was less than the growth rate of prices for the medications under investigation by 5–67%. The obtained results of a study of the socio-economic accessibility of medicines for type 2 diabetes monotherapy for the population of Ukraine Cliq, Ca.s., D against the background of reducing the rate of salary growth show a decrease in the dynamics of such availability in the period 2013–2016 years.

Authors and Affiliations

T. A. Germanyuk, T. I. Ivko, V. P. Bobruk

Keywords

Related Articles

Antibacterial properties of thioridazine

The emergence and spread of antibiotic-resistant strains of microorganisms reduces the effectiveness of antibiotic therapy and requires finding solutions to problems, one of which is the study of antimicrobial properties...

Luminescent determination of residues of trazodon hydrochloride and melatonin after cleaning pharmaceutical equipment

A prerequisite for ensuring the quality of medicines is their production in accordance with the rules of GMP (Good Manufacturing Practice for Medicinal Products), one of the most important requirements of which is equipm...

Research of physico-chemical and technological properties of thioctic acid

Characteristics and relevance of article topic. Analysis of the literature data shows that the thioctic acid preparations are widely used in the treatment of various diseases. At it’s parenteral application inter- and in...

Marketing research ukrainian market antiplatelet agents

Antiplatelets are present at prevention and therapy of cardiovascular diseases necessarily. The aim of this work is organizing of informational file about medicines with antiplatelet activity, determination of actuality...

Study on the development of liquid extract of cardiotonic action

At the Department of Industrial Pharmacy of the National University of Pharmacy, a complex cardiotonic action extract containing extracts of Crataegus охуaсanta fruits, Leonurus cardiaca herb, Melissa officinalis herb an...

Download PDF file
  • EP ID EP553990
  • DOI 10.32352/0367-3057.1.17.05
  • Views 49
  • Downloads 0

How To Cite

T. A. Germanyuk, T. I. Ivko, V. P. Bobruk (2017). Dynamics of accessibility of medicines for type 2 diabetes monotherapy in Ukraine. Фармацевтичний журнал, 1(1), 37-42. https://europub.co.uk/articles/-A-553990